Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
162.9 USD | -1.56% | -2.30% | -9.63% |
05-02 | UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating | MT |
05-01 | Repligen's Q1 Adjusted Earnings, Revenue Fall | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.63% | 9.25B | |
-4.82% | 183B | |
-0.18% | 108B | |
-3.44% | 67.51B | |
+3.84% | 50.67B | |
+9.17% | 44.7B | |
+2.41% | 40.95B | |
+5.87% | 26.8B | |
+2.06% | 26.71B | |
+12.66% | 24.62B |
- Stock Market
- Equities
- RGEN Stock
- News Repligen Corporation
- RBC Raises Price Target on Repligen to $225 From $200, Keeps Outperform Rating